Ild clinical trials

Explore recruiting ild clinical trials.

Recruiting ild studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Ild trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An open-label study to investigate the long-term safety and efficacy of belimumab in adults with interstitial lung disease (ILD) associated with systemic sclerosis (SSc) and other connective tissue diseases (CTD)

Greece, Denmark, Italy, Finland, Spain, France +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Fibroblast markers to tackle fibrosis in immune-mediated inflammatory diseases

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A PHASE 2A, OPEN-LABEL SINGLE ARM MULTICENTER EXPLORATORY STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF ORAL DOSES OF ROC-101 IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH) AND PULMONARY HYPERTENSION ASSOCIATED WITH INTERSTITIAL LUNG DISEASE (ILD-PH)

Spain, Italy, Poland, France, Latvia, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Cyclophosphamide and Azathioprine vs Tacrolimus in antisynthetase syndrome-related interstitial lung disease : multicentric randomized phase III trial (CATR-PAT)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

An Open-Label Extension Study to Assess the Safety, Tolerability, and Effectiveness of the Long-Term use of Treprostinil Palmitil Inhalation Powder in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease

Spain, Italy, Germany, Belgium

Phase II and Phase III (Integrated) EU CTIS Study details

Basket study for oligo-metastatic breast cancer - ANISE

Netherlands, France, Italy, Spain, Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

Ild trials by city

Ild in Toronto Ild in Vancouver Ild in Montreal Ild in Calgary Ild in Edmonton Ild in Ottawa Ild in Winnipeg Ild in Quebec City Ild in Hamilton Ild in Kitchener Ild in London Ild in Halifax Ild in New York Ild in Los Angeles Ild in Chicago Ild in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease